Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial

Autor: Griesel, Rulan *, Zhao, Ying, Simmons, Bryony, Omar, Zaayid, Wiesner, Lubbe, Keene, Claire M, Hill, Andrew M, Meintjes, Graeme, Maartens, Gary
Zdroj: In The Lancet HIV July 2023 10(7):e433-e441
Databáze: ScienceDirect